Whole‐exome sequencing predicted cancer epitope trees of 23 early cervical cancers in Chinese women

View/ Open
Author
Li, Xia
Guan, Yanfang
Gong, Yuhua
Yi, Xin
He, Cheng‐Yi
Qi, Ming
Chen, Zhi‐Ying
Published Version
https://doi.org/10.1002/cam4.953Metadata
Show full item recordCitation
Li, Xia, Hailiang Huang, Yanfang Guan, Yuhua Gong, Cheng‐Yi He, Xin Yi, Ming Qi, and Zhi‐Ying Chen. 2016. “Whole‐exome sequencing predicted cancer epitope trees of 23 early cervical cancers in Chinese women.” Cancer Medicine 6 (1): 207-219. doi:10.1002/cam4.953. http://dx.doi.org/10.1002/cam4.953.Abstract
Abstract Emerging evidence suggest that the heterogeneity of cancer limits the efficacy of immunotherapy. To search for optimal therapeutic targets for enhancing the efficacy, we used whole‐exome sequencing data of 23 early cervical tumors from Chinese women to investigate the hierarchical structure of the somatic mutations and the neo‐epitopes. The putative neo‐epitopes were predicted based on the mutant peptides’ strong binding with major histocompatibility complex class I molecules. We found that each tumor carried an average of 117 mutations and 61 putative neo‐epitopes. Each patient displayed a unique phylogenetic tree in which almost all subclones harbored neo‐epitopes, highlighting the importance of individual neo‐epitope tree in determination of immunotherapeutic targets. The alterations in FBXW7 and PIK3CA, or other members of the significantly altered ubiquitin‐mediated proteolysis and extracellular matrix receptor interaction related pathways, were proposed as the earliest changes triggering the malignant progression. The neo‐epitopes involved in these pathways, and located at the top of the hierarchy tree, might become the optimal candidates for therapeutic targets, possessing the potential to mediate T‐cell killing of the descendant cells. These findings expanded our understanding in early stage of cervical carcinogenesis and offered an important approach to assist optimizing the immunotherapeutic target selection.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269563/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:31731692
Collections
- HMS Scholarly Articles [17298]
Contact administrator regarding this item (to report mistakes or request changes)